News Updates
More Articles
- WHO warns of vaccine inequity, more monkeypox deaths
- ViiV, Medicines Patent Pool in licensing deal for cabotegravir
- Ipsen partners with Marengo in deal worth up to $1.6B
- EliTech, InfanDx sign MoU for encephalopathy test
- Hong Kong OKs Sinovac vaccine for kids 6 months to 3 years
Smart Safety Surveillance (3S): A Proven Approach to Building Functional LMIC Pharmacovigilance Systems
Smart Safety Surveillance (3S) is a product-focused, principles-based approach to building functional LMIC (low- and middle-income countries) pharmacovigilance (PV) systems that has been validated across multiple products and geographies.
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!